TriangleFenofibrate (NCT06191133)
Fenofibrate trial for Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer (NCT06191133). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with high grade cervical dysplasia or invasive cervical cancer that is HPV positive.
The idea: test fenofibrate, a cholesterol lowering pill already approved for heart conditions. Patients take it daily for two to four weeks before their planned procedure, surgery or chemoradiation. Researchers then study the tissue for changes in p53, a protein that helps prevent tumors.
This phase 1 study plans 24 patients. At University Hospitals Cleveland Medical Center's Case Comprehensive Cancer Center, Lindsay Ferguson leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.